|
1
|
El-Tawil AM: Trends on gastrointestinal
bleeding and mortality: Where are we standing? World J
Gastroenterol. 18:1154–1158. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Courtney RJ, Paul CL, Sanson-Fisher RW,
Macrae FA, Attia J and McEvoy M: Factors associated with
consultation behaviour for primary symptoms potentially indicating
colorectal cancer: A cross-sectional study on response to symptoms.
BMC Gastroenterol. 12:1002012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen CW, Jao SW, Wu CC, Ou JJ, Hsiao CW
and Chao PC: Massive lower gastrointestinal hemorrhage caused by a
large extraluminal leiomyoma of the colon: Report of a case. Dis
Colon Rectum. 51:975–978. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Casarella WJ, Kanter IE and Seaman WB:
Right-sided colonic diverticula as a cause of acute rectal
hemorrhage. N Engl J Med. 286:450–453. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Leitman IM, Paull DE and Shires GT 3rd:
Evaluation and management of massive lower gastrointestinal
hemorrhage. Ann Surg. 209:175–180. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Al Qahtani AR, Satin R, Stern J and Gordon
PH: Investigative modalities for massive lower gastrointestinal
bleeding. World J Surg. 26:620–625. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Imdahl A, Salm R, Rückauer K and Farthmann
EH: Diagnosis and management of lower gastrointestinal hemorrhage.
Retrospective analysis of 233 cases. Langenbecks Arch Chir.
376:152–157. 1991.(In German). View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thorpe B, Applebaum B, Esquivel RF, Krouse
RS and Fass R: Colon cancer presenting as upper-GI bleeding.
Gastrointest Endosc. 63:343–345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gralnek IM: Gastrointestinal bleeding.
Gastrointest Endosc. 76:506–509. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yokoyama T, Kondo H, Yokota T, Tokue Y,
Saito D, Shimada Y and Sugihara K: Colonoscopy for frank bloody
stools associated with cancer chemotherapy. Jpn J Clin Oncol.
27:111–114. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ross WB, Morris DL and Clingan PR: Major
upper gastrointestinal haemorrhage associated with hepatic arterial
chemoperfusion. Aust NZ J Surg. 66:816–819. 1996. View Article : Google Scholar
|
|
12
|
Koucky K, Wein A, Konturek PC, Albrecht H,
Reulbach U, Männlein G, Wolff K, Ostermeier N, Busse D, Golcher H,
et al: Palliative first-line therapy with weekly high-dose
5-fluorouracil and sodium folinic acid as a 24-hour infusion (AIO
regimen) combined with weekly irinotecan in patients with
metastatic adenocarcinoma of the stomach or esophagogastric
junction followed by secondary metastatic resection after
downsizing. Med Sci Monit. 17:CR248–CR258. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moriwaki T, Bando H, Takashima A, Yamazaki
K, Esaki T, Yamashita K, Fukunaga M, Miyake Y, Katsumata K, Kato S,
et al: Bevacizumab in combination with irinotecan, 5-fluorouracil,
and leucovorin (FOLFIRI) in patients with metastatic colorectal
cancer who were previously treated with oxaliplatin-containing
regimens: A multicenter observational cohort study (TCTG 2nd-BV
study). Med Oncol. 29:2842–2848. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Trotti A, Colevas AD, Setser A, et al:
CTCAE v3.0: development of a comprehensive grading system for the
adverse effects of cancer treatment. Semin Radiat Oncol.
13:176–181. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hurwitz H, Fehrenbacher L, Novotny W, et
al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for
metastatic colorectal cancer. N Engl J Med. 350:2335–2342. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giantonio BJ, Catalano PJ, Meropol NJ, et
al: Eastern Cooperative Oncology Group Study E3200: Bevacizumab in
combination with oxaliplatin, fluorouracil, and leucovorin
(FOLFOX4) for previously treated metastatic colorectal cancer:
Results from the Eastern Cooperative Oncology Group Study E3200. J
Clin Oncol. 25:1539–1544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hayashi H, Okamoto I and Nakagawa K:
Perirenal hematoma associated with bevacizumab treatment. Invest
New Drugs. 30:808–809. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Khasraw M, Holodny A, Goldlust SA and
DeAngelis LM: Intracranial hemorrhage in patients with cancer
treated with bevacizumab: The Memorial Sloan-Kettering experience.
Ann Oncol. 23:458–463. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Uysal M, Goksu SS, Coskun HS, Savas B,
Ozdogan M and Bozcuk H: Intraarticular hemorrhage due to
bevacizumab in a patient with metastatic colorectal cancer: A case
report. J Med Case Rep. 6:1882012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsuchida K, Honjoh Y, Asari M, Osawa E,
Numata K, Yoshida T, Osaragi T, Yoneyama K, Kasahara A, Yamamoto Y,
et al: A case of rectal hemorrhage during chemotherapy with
bevacizumab for local recurrence of rectal cancer. Gan To Kagaku
Ryoho. 39:675–677. 2012.(In Japanese). PubMed/NCBI
|
